Financial

Etiometry and Terumo Cardiovascular Announce Partnership to Deliver Enhanced Monitoring Insights for Adult Cardiac Surgery Patients

New partnership will enable clinical decision-support solutions to improve perioperative care BOSTON & ANN ARBOR, Mich.–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for critical care, today jointly announced a new collaboration with Terumo Cardiovascular, a global leader in cardiovascular surgery technologies and a subsidiary of Japan-based Terumo Corporation (TSE: 4543). The partnership […]

Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates

– TN-201 MYBPC3 gene therapy product candidate for the leading genetic cause of hypertrophic cardiomyopathy granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) – Expanded leadership team appointing Leone Patterson as Chief Financial and Business Officer and Matt Pollman, MD, as SVP, Clinical Development – Completed Initial Public […]

atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors

BAAR, Switzerland and MOUNTAIN VIEW, Calif., Sept. 8, 2021 /PRNewswire/ — atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announced the appointment of Andrew Cleeland to the company’s Board of Directors. With over thirty years of experience, including specific expertise bringing game-changing technologies to […]

Cardio Partners, a Sarnova company, Announce the Acquisition of Allied 100

The combination of companies expands access to sudden cardiac arrest (SCA) preparedness solutions to customers nationwide BRENTWOOD, Tenn., Sept. 7, 2021 /PRNewswire/ — Cardio Partners, Inc., a company of Sarnova, Inc. and a national leader in providing emergency preparedness solutions, announced today that it has acquired Allied 100, LLC, a nationwide distributor of automated external […]

Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant

To Advise the Company’s Mitral Transcatheter Edge-to-edge Repair Project and the Company in General SUZHOU, China, Sept. 6, 2021 /PRNewswire/ — Peijia Medical Limited (HKEX: 9996) is pleased to announce Saibal Kar MD, FACC, FSCAI, board-certified interventional cardiologist has agreed to become our exclusive consultant in China to advise the research and development of our Mitral Transcatheter […]

XACT Robotics® Appoints New Vice President, Sales and Marketing

Christopher Horton brings nearly 30 years of experience in the medical device and technology industry HINGHAM, Mass., Sept. 7, 2021 /PRNewswire/ — XACT Robotics®, the developer of the world’s first and only hands-free robotic system for CT-guided percutaneous procedures, the XACT ACE™ Robotic System, today announced that Christopher Horton has joined the company as […]

Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC

Acquisition builds upon Abbott’s leading vascular portfolio, adding mechanical thrombectomy devices for treating patients with peripheral blood clots ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ — Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood […]

Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.

NEW YORK, Sept. 1, 2021 /PRNewswire/ — Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) (“CHAQ”), a special purpose acquisition company sponsored by Chardan Capital Markets (“Chardan”), today announced the results for the proposals considered and voted upon by its stockholders at its special meeting held on September 1, 2021 (the “Special Meeting”), regarding the proposed […]

Sequana Medical announces H1 2021 results and provides business update

alfapump® – Positive results from second interim analysis of POSEIDON pivotal study; awaiting FDA approval on POSEIDON pivotal study expansion alfapump® – FDA regulatory submission now expected in mid-2023 due to worldwide supply shortage of electronic components; European commercial activities and clinical studies unaffected alfapump DSR® – Strong top-line results from RED DESERT; interim results […]